Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 242 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

29 trials in Phase 3/4

Results Transparency

2%

1 of 63 completed trials have results

Key Signals

60 recruiting1 with results

Enrollment Performance

Analytics

N/A
96(72.7%)
Phase 4
25(18.9%)
Phase 3
4(3.0%)
Phase 1
3(2.3%)
Phase 2
2(1.5%)
Early Phase 1
2(1.5%)
132Total
N/A(96)
Phase 4(25)
Phase 3(4)
Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (242)

Showing 20 of 242 trials
NCT07572253Not ApplicableNot Yet Recruiting

A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibrillation

Role: lead

NCT05605418Not ApplicableCompleted

Study of a Comprehensive Intelligent Hypertension managEment SyStem

Role: lead

NCT07551518Completed

Retrospective Algorithm Validation of IVUS-FFR in Patients

Role: lead

NCT07317804Phase 4Not Yet Recruiting

Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)

Role: lead

NCT07535333Not ApplicableNot Yet Recruiting

Exercise-Targeted Smart Lifestyle Management

Role: lead

NCT07302659Not ApplicableRecruiting

Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG

Role: lead

NCT07524998Recruiting

A Chinese Multicenter Study on Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease

Role: lead

NCT07499830Completed

Performance of an OCR-Prompt-LLM Integrated Workflow for Extracting Multi-dimensional Clinical Data in Ischemic Heart Disease

Role: lead

NCT05320627Phase 4Completed

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

Role: lead

NCT07367724Phase 2Recruiting

Ademetionine in Obstructive Hypertrophic Cardiomyopathy

Role: lead

NCT06554301Phase 1Recruiting

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

Role: lead

NCT06073366Completed

Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study

Role: lead

NCT07482683Not Yet Recruiting

Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach

Role: lead

NCT07476456Not Yet Recruiting

Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death

Role: lead

NCT06787430Phase 4Not Yet Recruiting

Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI

Role: lead

NCT07411768Not ApplicableNot Yet Recruiting

Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement

Role: lead

NCT06055452Phase 4Recruiting

Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension

Role: lead

NCT07449429Not Yet Recruiting

A Privacy-Preserving OCR-LLM System for Coronary Syndrome Subtyping From Admission HPI: Multicenter Validation in China and the US

Role: lead

NCT07446023Not ApplicableRecruiting

IVUS-FFR Accuracy for Coronary Stenosis

Role: lead

NCT07414966Not ApplicableNot Yet Recruiting

Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation

Role: lead